个人文章:USCOM V:预防和治疗激素癌症治疗皮肤副作用的实用算法
Journal of drugs in dermatology : JDD
|April 8, 2025
概括
一个新的算法有助于管理激素癌症治疗的皮肤副作用. 这种方法有助于临床医生预防和治疗不良事件,改善患者的生活质量.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 临床治疗学 临床治疗学
背景情况:
- 预计到2024年,美国将有超过200万例癌症诊断.
- 荷尔蒙疗法对荷尔蒙依赖性癌症至关重要,但会导致皮肤问题,如老化,脱光,,脆的指甲,脱发不良,.
- 管理这些皮肤不良事件对于患者的生活质量至关重要.
研究的目的:
- 创建一个多学科的算法来管理由激素癌症治疗引起的皮肤问题.
- 为医生提供一种结构化的患者护理方法.
主要方法:
- 进行了系统的文献审查.
- 使用了经过修改的Delphi流程,涉及一个顾问小组.
- 该算法将证据与专家的临床经验相结合.
主要成果:
- 开发了一种算法,以个性化预防和管理皮肤不良事件.
- 该算法使用CTCAE v.5对癌症治疗相关皮肤疾病的分级.
- 提供管理建议来补充算法.
结论:
- 一个由医生开发的算法可以指导从激素治疗中预防,识别和治疗皮肤问题.
- 实施这个算法可能会减少治疗中断.
- 对于接受激素癌症治疗的患者来说,预计会改善患者的治疗结果和生活质量.
相关概念视频
Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Skin Cancer
5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)

